Evaluation of the rationality and safety of Shuxuening injection in 212 outpatients
- Author:
Li-Wei JI
1
Author Information
- Publication Type:Journal Article
- Keywords: Adverse reaction; Rationality; Safety; Shuxuening injection
- From: Chinese Pharmaceutical Journal 2014;49(1):76-79
- CountryChina
- Language:Chinese
- Abstract: OBJECTIVE: To investigate the rationality and safety of Shuxuening injection used in our hospital. METHODS: Two hundred and twelve outpatients (77 males, 135 females) were selected. Survey forms designed for this research were filled in with items including age, sex, clinical diagnosis, symptom, dosage, course of treatment, adverse reactions due to the injection and outcome. Data were analyzed statistically. RESULTS: For the 212 cases with an average age of (59.8±12.8) yeas, the average dose of Shuxuening injection was 20 mL, given once daily by intravenous infusion; the duration of therapy was (7.5±3.2) d; the rate of adverse reactions was 5.66%. CONCLUSION: Shuxuening injection is used rationally in our hospital, and it is generally safe when used according to the labeling.
